Clinical Trial Update: A Study to Learn About the Study Medicine Bosulif in Adult Patients With Chronic Myeloid Leukemia(CML).

View source ↗

Summary

Pfizer is recruiting adults with chronic myeloid leukemia for a clinical trial of Bosulif (bosutinib) to study its safety and potential efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• BOSULIF (bosutinib)

Snippet

Sponsor: Pfizer | Conditions: Chronic Leukemia Myelogenous | Status: RECRUITING